Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
- Not stated
- Not stated
- Jun 12, 2025
Official announcement on nih_guide+grants_gov · opens the funder's page. Always confirm dates there.
Summary
The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral (Parent F32) award is to enable promising postdoctoral students to obtain individualized, mentored research training from appropriate faculty sponsors while conducting biomedical research in scientific health-related fields relevant to… […]
Other topics in this solicitation
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
NIH Research Project Grant (Parent R01 Clinical Trial Required)
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
NICHD Small Research Grant Program (R03 Clinical Trial Required)
$50k
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- All 6 review criteria reviewers score this against, extracted from this announcement
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards
More from National Institutes of Health
NIH Director’s Early Independence Award (DP5 Clinical Trial Optional)
$350k
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
$250k
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
$350k